BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38840273)

  • 1. The Impact of High Intensity Focused Ultrasound (HIFU) on Tumor-Specific Immune Responses of Prostate Cancer.
    Chen W; He L; Huang H; Zeng X; Fu G; Liu Y; Liang Y
    Arch Esp Urol; 2024 May; 77(4):322-330. PubMed ID: 38840273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy.
    Tang R; He H; Lin X; Wu N; Wan L; Chen Q; Hu Y; Cheng C; Cao Y; Guo X; Zhou Y; Xiong X; Zheng M; Wang Q; Li F; Zhou Y; Li P
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36650023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Mechanical High-Intensity Focused Ultrasound Ablation with Chemotherapy for Augmentation of Anticancer Immune Responses.
    Li C; Lu Y; Cheng L; Zhang X; Yue J; Liu J
    Mol Pharm; 2021 May; 18(5):2091-2103. PubMed ID: 33886331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.
    Hu Z; Yang XY; Liu Y; Sankin GN; Pua EC; Morse MA; Lyerly HK; Clay TM; Zhong P
    J Transl Med; 2007 Jul; 5():34. PubMed ID: 17625013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation.
    van den Bijgaart RJE; Mekers VE; Schuurmans F; Raaijmakers TK; Wassink M; Veltien A; Dumont E; Heerschap A; Fütterer JJ; Adema GJ
    Front Immunol; 2022; 13():1038347. PubMed ID: 36569907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies.
    van den Bijgaart RJ; Eikelenboom DC; Hoogenboom M; Fütterer JJ; den Brok MH; Adema GJ
    Cancer Immunol Immunother; 2017 Feb; 66(2):247-258. PubMed ID: 27585790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.
    Huang X; Yuan F; Liang M; Lo HW; Shinohara ML; Robertson C; Zhong P
    PLoS One; 2012; 7(7):e41632. PubMed ID: 22911830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities.
    Cirincione R; Di Maggio FM; Forte GI; Minafra L; Bravatà V; Castiglia L; Cavalieri V; Borasi G; Russo G; Lio D; Messa C; Gilardi MC; Cammarata FP
    Ultrasound Med Biol; 2017 Feb; 43(2):398-411. PubMed ID: 27780661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablative Focused Ultrasound Synergistically Enhances Thermally Triggered Chemotherapy for Prostate Cancer in Vitro.
    Arora JS; Murad HY; Ashe S; Halliburton G; Yu H; He J; John VT; Khismatullin DB
    Mol Pharm; 2016 Sep; 13(9):3080-90. PubMed ID: 27383214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused ultrasound-aided immunomodulation in glioblastoma multiforme: a therapeutic concept.
    Cohen-Inbar O; Xu Z; Sheehan JP
    J Ther Ultrasound; 2016; 4():2. PubMed ID: 26807257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment.
    Sun BL
    Prostate; 2021 Nov; 81(15):1125-1134. PubMed ID: 34435699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.
    Fite BZ; Wang J; Kare AJ; Ilovitsh A; Chavez M; Ilovitsh T; Zhang N; Chen W; Robinson E; Zhang H; Kheirolomoom A; Silvestrini MT; Ingham ES; Mahakian LM; Tam SM; Davis RR; Tepper CG; Borowsky AD; Ferrara KW
    Sci Rep; 2021 Jan; 11(1):927. PubMed ID: 33441763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity focused ultrasound in the management of prostate cancer.
    Chaussy C; Thüroff S
    Expert Rev Med Devices; 2010 Mar; 7(2):209-17. PubMed ID: 20214427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-Changeable Nanoparticle-Mediated Energy Conversion Promotes Highly Efficient High-Intensity Focused Ultrasound Ablation.
    Zeng Z; Liu JB; Peng CZ
    Curr Med Chem; 2022 Mar; 29(8):1369-1378. PubMed ID: 34238143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.
    Chaussy CG; Thüroff S
    J Endourol; 2017 Apr; 31(S1):S30-S37. PubMed ID: 28355119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes.
    Xia JZ; Xie FL; Ran LF; Xie XP; Fan YM; Wu F
    Ultrasound Med Biol; 2012 Aug; 38(8):1363-71. PubMed ID: 22633269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound Therapy, Chemotherapy and Their Combination for Prostate Cancer.
    Lopez W; Nguyen N; Cao J; Eddow C; Shung KK; Lee NS; Chow MSS
    Technol Cancer Res Treat; 2021; 20():15330338211011965. PubMed ID: 34013821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.
    Peng S; Hu P; Xiao YT; Lu W; Guo D; Hu S; Xie J; Wang M; Yu W; Yang J; Chen H; Zhang X; Zhu Y; Wang Y; Yang Y; Zhu G; Chen S; Wang J; Zhang B; Chen W; Wu H; Sun Z; Ding T; Zhang H; Yi Z; Liu M; Ren S
    Clin Cancer Res; 2022 Feb; 28(3):552-567. PubMed ID: 34740924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.